To assess the potential role of BMI-1 in regulation of invasion and metastasis ability of pancreatic CSCs and the underlying mechanism, we firstly investigated the association of BMI-1 and CSCs maker CD133 with clinicopathological parameters and survival of pancreatic cancer patients. Here, BMI1 is linked to familial pancreatic carcinoma.